2 Global Drug Discovery Services Quarterly Market Size Analysis

• 2.1 Drug Discovery Services Business Impact Assessment - COVID-19
  • 2.1.1 Global Drug Discovery Services Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Drug Discovery Services Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 By Players, Global Drug Discovery Services Quarterly Market Size, 2019 VS 2020
• 3.2 By Players, Drug Discovery Services Headquarters and Area Served
• 3.3 Date of Key Players Enter into Drug Discovery Services Market
• 3.4 Key Players Drug Discovery Services Product Offered
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Drug Discovery Services Segments, By Type

• 4.1 Introduction
  • 1.4.1 Chemical Services
  • 1.4.2 Biological Services
  • 1.4.3 Lead Optimization
  • 1.4.4 Lead Identification and Screening
• 4.2 By Type, Global Drug Discovery Services Market Size, 2019-2021

5 Impact of Covid-19 on Drug Discovery Services Segments, By Application

• 5.1 Overview
  • 5.5.1 Pharmaceutical Companies
  • 5.5.2 Other
• 5.2 By Application, Global Drug Discovery Services Market Size, 2019-2021
  • 5.2.1 By Application, Global Drug Discovery Services Market Size by Application, 2019-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Quintiles
  • 7.1.1 Quintiles Business Overview
  • 7.1.2 Quintiles Drug Discovery Services Quarterly Revenue, 2020
  • 7.1.3 Quintiles Drug Discovery Services Product Introduction
  • 7.1.4 Quintiles Response to COVID-19 and Related Developments
• 7.2 Charles River Laboratories
  • 7.2.1 Charles River Laboratories Business Overview
  • 7.2.2 Charles River Laboratories Drug Discovery Services Quarterly Revenue, 2020
  • 7.2.3 Charles River Laboratories Drug Discovery Services Product Introduction
  • 7.2.4 Charles River Laboratories Response to COVID-19 and Related Developments
• 7.3 Aptuit
  • 7.3.1 Aptuit Business Overview
  • 7.3.2 Aptuit Drug Discovery Services Quarterly Revenue, 2020
  • 7.3.3 Aptuit Drug Discovery Services Product Introduction
  • 7.3.4 Aptuit Response to COVID-19 and Related Developments
• 7.4 Evotec
  • 7.4.1 Evotec Business Overview
  • 7.4.2 Evotec Drug Discovery Services Quarterly Revenue, 2020
  • 7.4.3 Evotec Drug Discovery Services Product Introduction
  • 7.4.4 Evotec Response to COVID-19 and Related Developments
• 7.5 GenScript
  • 7.5.1 GenScript Business Overview
  • 7.5.2 GenScript Drug Discovery Services Quarterly Revenue, 2020
  • 7.5.3 GenScript Drug Discovery Services Product Introduction
  • 7.5.4 GenScript Response to COVID-19 and Related Developments
• 7.6 PPD
  • 7.6.1 PPD Business Overview
  • 7.6.2 PPD Drug Discovery Services Quarterly Revenue, 2020
  • 7.6.3 PPD Drug Discovery Services Product Introduction
  • 7.6.4 PPD Response to COVID-19 and Related Developments
• 7.7 WuXi AppTec
  • 7.7.1 WuXi AppTec Business Overview
  • 7.7.2 WuXi AppTec Drug Discovery Services Quarterly Revenue, 2020
  • 7.7.3 WuXi AppTec Drug Discovery Services Product Introduction
  • 7.7.4 WuXi AppTec Response to COVID-19 and Related Developments
• 7.8 AMRI
  • 7.8.1 AMRI Business Overview
  • 7.8.2 AMRI Drug Discovery Services Quarterly Revenue, 2020
  • 7.8.3 AMRI Drug Discovery Services Product Introduction
  • 7.8.4 AMRI Response to COVID-19 and Related Developments

8 Key Findings

9 Appendix

• 9.1 About US

This report covers market size and forecasts of Drug Discovery Services, including the following market information:
Global Drug Discovery Services Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Drug Discovery Services Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Drug Discovery Services Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Drug Discovery Services Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players
Major competitors identified in this market include Quintiles, Charles River Laboratories, Aptuit, Evotec, GenScript, PPD, WuXi AppTec, AMRI, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Chemical Services
Biological Services
Lead Optimization
Lead Identification and Screening

Based on the Application:
Pharmaceutical Companies
Other